Home / WINDLAS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does WINDLAS.NS make money? Does WINDLAS.NS have pricing power? What's the Earnings Whisper? Will WINDLAS.NS profit more as the business scales? What is WINDLAS.NS's management track record? Is WINDLAS.NS's current price justified?

Windlas Biotech Limited

₹917.4 +$115.70 (+14.43%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹923.5

Day Range

₹891.1₹937.7

Year Range

₹697.4₹1181.9

Market Cap

18.93B

AVG Volume

121.72K

Trailing/Forward PE

28.91/-

PEG ratio

15.81

Dividend Yield

0.69%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

WINDLAS.NS Revenue (INR) by year
Period	Revenue (INR)
2026	9.04B
2025	7.6B
2024	6.31B
2023	5.13B
2022	4.63B
2021	4.27B

Net Income (INR) · A

WINDLAS.NS Net Income (INR) by year
Period	Net Income (INR)
2026	664.56M
2025	609.94M
2024	581.87M
2023	426.26M
2022	380.89M
2021	158.34M

Operating Income (INR) · A

WINDLAS.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	739.99M
2025	661.22M
2024	848.53M
2023	479.24M
2022	405.89M
2021	443.28M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Windlas Biotech Limited

Video analysis: WINDLAS.NS

News: WINDLAS.NS

Similar companies